Plum SEC
  • Korean Market
  • Community
  • Contact Us

Korean Market

  • Reset (View All)

  • ★★★★★
  • ★★★★
  • ★★★
  • ★★
  • ★

  • ★

  • ★
  • ★★
  • ★★★
  • ★★★★
  • ★★★★★
AI Disclosures
MATR
Aprogen Biologics
★★
Issuance of 10 Billion KRW 19th Convertible Bonds, Premium Conversion Price (4,433 KRW) via Third-Party Allotment to Largest Shareholder
 9h ago
EXCH
Aprogen Biologics
★
Completion of 2 Billion Won Third-Party Allotment Capital Increase (592,593 Shares)
 05/16/2026, 07:51 PM
EXCH
Aprogen Biologics
★★★
Major shareholder Aprogen increases stake to 58.73% via third-party allotment
 05/16/2026, 07:51 PM
PERI
Aprogen Biologics
★★
Aprogen Biologics Reports Q1 2026 Operating Loss of KRW 13.6B, Implements Reverse Stock Split and Rights Offering
 05/14/2026, 04:51 PM
OWNR
Aprogen Biologics
★
Submission of Report on Ownership of Specific Securities by Executives and Major Shareholders
 05/08/2026, 04:32 PM
OWNR
Aprogen Biologics
★★
Large Shareholding Report Filed for Management Influence - Stake Change Due to Capital Reduction
 05/08/2026, 04:21 PM
OWNR
Aprogen Biologics
★
Submission of Report on Ownership of Specific Securities by Executives and Major Shareholders
 05/08/2026, 04:09 PM
OWNR
Aprogen Biologics
★
Executives/Major Shareholders Securities Ownership Report Filed (No Changes)
 05/08/2026, 04:06 PM
OWNR
Aprogen Biologics
★
Executive/Major Shareholder Specific Securities Ownership Report Filed
 05/08/2026, 04:05 PM
OWNR
Aprogen Biologics
★
Report on Ownership of Specific Securities by Executives/Major Shareholders (No Change)
 05/08/2026, 04:02 PM
  • «
  • 1
  • 2
  • »
한국어 | English | 中文 | 日本語
Plum SEC © 2026.05.25
The information provided on this site is for reference only and we do not guarantee its accuracy or completeness. Users are solely responsible for any investment decisions made based on this information.